Biotron Ltd

BIT

Company Profile

  • Business description

    Biotron Ltd is an Australian biotechnology company focused on the development and commercialization of antiviral therapies and neuroscience-related products. The company reports two operating segments: SedRx, focused on anesthetic and neuroscience products, and Viron, which encompasses antiviral drug development programs. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

  • Contact

    66 Hunter Street
    Level 2
    SydneyNSW2000
    AUS

    T: +61 293003344

    https://www.biotron.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

    4

Stocks News & Analysis

stocks

Overvalued ASX share has overly ambitious profit target

We think the new profit target is aggressive and unlikely to be met.
stocks

7 undervalued US stocks that crushed earnings

Arista and GE Vernova remain among the cheapest Morningstar-covered stocks after strong earnings beats.
stocks

Undervalued ASX share hitting on all cylinders

Strong performance across all segments in latest earnings release.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,009.50155.90-1.70%
CAC 408,352.0016.91-0.20%
DAX 4026,598.64151.31-0.57%
Dow JONES (US)51,608.17739.38-1.41%
FTSE 10010,881.5521.01-0.19%
HKSE23,571.61182.23-0.77%
NASDAQ24,509.76626.52-2.49%
Nikkei 22558,815.14846.88-1.42%
NZX 50 Index14,304.901.130.01%
S&P 5007,416.59145.08-1.92%
S&P/ASX 2008,895.50149.20-1.65%
SSE Composite Index3,602.070.50-0.01%

Market Movers